Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.87
+0.91 (6.52%)
At close: Aug 10, 2026, 4:00 PM EDT
14.79
-0.08 (-0.54%)
Pre-market: Aug 11, 2026, 4:55 AM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $11.86 billion as of August 11, 2026. Its market cap has decreased by -44.27% in one year.
Market Cap
11.86B
Enterprise Value
11.19B
1-Year Change
-44.27%
Ranking
Category
Stock Price
$14.87
ChartMarket Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $11.86B, an increase of 9,868.52%. That is a compound annual growth rate of 49.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 11.86B | -8.89% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 12.38B |
| BioMarin Pharmaceutical | 12.35B |
| Corcept Therapeutics | 11.97B |
| Madrigal Pharmaceuticals | 11.78B |
| Halozyme Therapeutics | 11.70B |
| ABIVAX Société Anonyme | 11.37B |
| Bio-Techne | 11.26B |
| Axsome Therapeutics | 10.95B |